KMT2D and PIK3CA Mutation As Potential Factors to Predict Adjuvant Chemotherapy Efficacy in Surgical Triple Negative Breast Cancer.Xue Wang,Feng Du,Jian Yue,Yiran Si,Lina Cui,Bei Zhang,Xiaochen Zhao,Binghe Xu,Peng YuanCancer Research（2022）引用 0|浏览24AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
